M&G Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-257
| Closed | -$211K | – | 426 |
|
|
2023
Q1 | $211K | Sell |
257
-6,979
| -96% | -$5.74M | ﹤0.01% | 383 |
|
|
2022
Q4 | $5.22M | Hold |
7,236
| – | – | 0.03% | 218 |
|
|
2022
Q3 | $4.99K | Sell |
7,236
-15
| -0.2% | -$10 | 0.03% | 220 |
|
|
2022
Q2 | $4.29K | Sell |
7,251
-107
| -1% | -$63 | 0.03% | 259 |
|
|
2022
Q1 | $5.14K | Sell |
7,358
-13
| -0.2% | -$9 | 0.01% | 253 |
|
|
2021
Q4 | $4.66K | Sell |
7,371
-13,337
| -64% | -$8.43K | 0.01% | 258 |
|
|
2021
Q3 | $12.5K | Buy |
20,708
+8,741
| +73% | +$5.29K | 0.03% | 248 |
|
|
2021
Q2 | $6.69K | Sell |
11,967
-915
| -7% | -$512 | 0.02% | 347 |
|
|
2021
Q1 | $6.09K | Sell |
12,882
-1,440
| -10% | -$681 | 0.02% | 222 |
|
|
2020
Q4 | $6.92K | Buy |
14,322
+410
| +3% | +$198 | 0.04% | 212 |
|
|
2020
Q3 | $7.79M | Sell |
13,912
-1,427
| -9% | -$799K | 0.08% | 187 |
|
|
2020
Q2 | $9.57M | Buy |
15,339
+6,613
| +76% | +$4.13M | 0.1% | 167 |
|
|
2020
Q1 | $4.26M | Sell |
8,726
-1,629
| -16% | -$795K | 0.05% | 217 |
|
|
2019
Q4 | $3.88M | Buy |
+10,355
| New | +$3.88M | 0.03% | 245 |
|